NWBO (Northwest Biotherapeutics) PB Ratio: (As of Jun. 25, 2026)


NWBO Northwest Biotherapeutics Inc NWBO
17 GF Score
Price $0.19
! 5 Warning Signs
View Full Analysis

What is Northwest Biotherapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Northwest Biotherapeutics's share price is $0.19. Northwest Biotherapeutics's Book Value per Share for the quarter that ended in Mar. 2026 was $-0.03. Hence, Northwest Biotherapeutics's PB Ratio of today is .

The historical rank and industry rank for Northwest Biotherapeutics's PB Ratio or its related term are showing as below:

NWBO's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.8
* Ranked among companies with meaningful PB Ratio only.

During the past 3 years, the average Book Value Per Share Growth Rate was 31.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 34.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 6.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Northwest Biotherapeutics was 68.30% per year. The lowest was -28.70% per year. And the median was 26.10% per year.

Back to Basics: PB Ratio


Northwest Biotherapeutics  (OTCPK:NWBO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Northwest Biotherapeutics PB Ratio Related Terms


Northwest Biotherapeutics PB Ratio Historical Data

* Premium members only.

The historical data trend for Northwest Biotherapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Northwest Biotherapeutics PB Ratio Chart

Northwest Biotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Northwest Biotherapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NWBO vs PROK, AVIR, IMRX: PB Ratio Comparison

For the Biotechnology subindustry, Northwest Biotherapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Northwest Biotherapeutics PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Northwest Biotherapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Northwest Biotherapeutics's PB Ratio falls into.


NWBO
17GF Score
Northwest Biotherapeutics Inc NWBO
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Northwest Biotherapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Northwest Biotherapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=0.19/-0.031
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Northwest Biotherapeutics Business Description

Other Exchanges NBYB:Germany
Address 4800 Montgomery Lane, Suite 800, Bethesda, MD, USA, 20814
Northwest Biotherapeutics Inc a biotechnology company focused on developing personalized immune therapies for cancer. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S Food and Drug Administration.
17GF Score

Get the complete analysis for NWBO

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price